Avricore expands HealthTab to north-central London

Executive Summary

• Avricore Health Inc. has expanded its HealthTab platform into north-central London, marking the second NHS Integrated Care Board (ICB) to adopt the initiative after northeast London.
• Six new HealthTab systems were deployed in this phase, bringing the total United Kingdom network to 13 participating pharmacies.
• The expansion aims to tackle health inequalities through cholesterol screening and cardiovascular disease prevention, leveraging a multidisciplinary partnership with major NHS trusts and academic institutions.

Key Details

• Expansion Scope: Deployment of six new HealthTab systems in north-central London pharmacies.
• Network Growth: The UK network of participating pharmacies has expanded from 7 to 13 locations.
• Strategic Partners: The initiative is delivered in collaboration with Barts Health NHS Trust, NHS North Central London, NHS North East London, North East London Local Pharmaceutical Committee, UCLPartners, and Heart U.K.
• Clinical Focus: The program targets cardiovascular disease (CVD) prevention and management, focusing on underserved populations and reducing health disparities through earlier detection and timely intervention.
• Regulatory Context: The expansion precedes a critical milestone in September 2026, when the NHS Community Pharmacy Independent Prescribing Pathfinder Programme will grant community pharmacists authority to diagnose and prescribe for chronic conditions like diabetes and CVD.
• Technology Integration: In January of the current year, HealthTab integrated with Patient Knows Best (PKB), enabling real-time pharmacy test results to be integrated into patients' personal NHS health records. PKB currently serves 4.8 million users.
• Economic Impact: A report by the NHS Confederation (released Oct 11, 2024) highlighted community-based CVD screening as a high-return investment, citing a return of £7.52 for every £1 spent on cardiovascular screening within one year.
• HealthTab Capabilities: The platform provides lab-accurate point-of-care testing via finger prick, covering up to 23 biomarkers (including HbA1c, Lipid Profile, eGFR) and recently added bacterial/viral tests (strep, COVID-19).
• Revenue Model: The HealthTab network model generates revenue through equipment leasing, consumables, direct access testing, disease prevention programs, sponsored health programs, decentralized clinical trials, real-world data (RWD) sets, and third-party API integrations.

Notable Quotes

• "This initiative is fundamentally changing how healthcare is delivered," said Rodger Seccombe, chief executive officer of Avricore Health. "By empowering pharmacists to take a leading role in chronic disease prevention and patient care, we're making health care more effective, more accessible and more responsive to the needs of both patients and providers."
• "Building on the success of our work in northeast London, we're proud to see this innovative model expand into our neighbouring ICB. By integrating specialist cardiovascular expertise into neighbourhood health teams and community pharmacies, we are enabling earlier detection, timely intervention and more equitable care," said Prof. Riyaz Patel, clinical lead for prevention, Barts Health NHS Trust.